Literature DB >> 29433709

State-of-the-Art Modalities for Peripheral Lung Nodule Biopsy.

Satish Kalanjeri1, Robert C Holladay2, Thomas R Gildea3.   

Abstract

Lung nodules are being increasingly detected, particularly with lung cancer screening with low-dose computed tomography. Although the vast majority of lung nodules are benign, many often require tissue diagnosis. Several modalities to obtain diagnostic tissue from peripheral lung nodules are available. Bronchoscopic modalities such as radial ultrasound and electromagnetic navigational bronchoscopy are becoming increasingly used because of their superior safety profile and improving diagnostic yield. Although these modalities continue to become more advanced, newer and complementary technologies appear promising.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ENB; Electromagnetic navigational bronchoscopy; Lung cancer; Peripheral pulmonary nodules; Radial ultrasound; Solitary pulmonary nodule

Mesh:

Year:  2017        PMID: 29433709     DOI: 10.1016/j.ccm.2017.11.007

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  3 in total

1.  CT-guided fine-needle aspiration biopsy of solitary pulmonary nodules under 15 mm in diameter: time for an afterthought?

Authors:  Davide Tosi; Paolo Mendogni; Rosaria Carrinola; Alessandro Palleschi; Lorenzo Rosso; Eleonora Bonaparte; Fulvia Milena Cribiù; Stefano Ferrero; Gianluca Bonitta; Mario Nosotti
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

2.  Shape-sensing robotic-assisted bronchoscopy for pulmonary nodules: initial multicenter experience using the Ion™ Endoluminal System.

Authors:  Michael J Simoff; Michael A Pritchett; Janani S Reisenauer; David E Ost; Adnan Majid; Colleen Keyes; Roberto F Casal; Mihir S Parikh; Javier Diaz-Mendoza; Sebastian Fernandez-Bussy; Erik E Folch
Journal:  BMC Pulm Med       Date:  2021-10-16       Impact factor: 3.317

Review 3.  Role of circular RNAs in the diagnosis, regulation of drug resistance and prognosis of lung cancer.

Authors:  Chengpeng Sang; Dingyu Rao; Caixia Wu; Yao Xia; Maoyan Si; Zhixian Tang
Journal:  Oncol Lett       Date:  2022-07-07       Impact factor: 3.111

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.